---
figid: PMC8926109__gr2_lrg
figtitle: '2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of
  COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae
  of SARS-CoV-2 Infection, and Return to Play'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8926109
filename: gr2_lrg.jpg
figlink: /pmc/articles/PMC8926109/figure/fig2/
number: F2
caption: 'Framework for Evaluating and Managing Cardiovascular Sequelae of COVID-19
  in AdultsGold and purple boxes = COVID-19 symptoms. Orange boxes = cardiac testing.
  Red and blue boxes = diagnoses (sequelae). ∗Includes elevated cTn; ECG with diffuse
  T-wave inversion, ST-segment elevation without reciprocal ST-segment depression,
  and/or prolongation of the QRS complex duration; and echocardiogram with ventricular
  wall motion abnormalities, often in a noncoronary distribution, and/or abnormal
  ventricular strain. †Informed by the presentation and may include coronary angiography
  for suspected acute coronary syndrome or CT pulmonary angiography for suspected
  pulmonary embolism (see ). ‡Includes other laboratory testing (eg, complete blood
  count, basic metabolic panel, C-reactive protein), an ambulatory rhythm monitor,
  a chest X-ray or CT imaging, and pulmonary function tests, along with additional
  testing for suspected PASC-CVD or PASC-CVS (see ). §For patients with myocarditis,
  medical therapy may include immunosuppressive drugs (eg, corticosteroids); for patients
  with pericardial involvement, medical therapy may include nonsteroidal anti-inflammatory
  drugs, colchicine, and corticosteroids (see ). ‖See . ¶For patients with PASC-CVS,
  empiric medical therapy may include a beta-blocker, a non-dihydropyridine calcium-channel
  blocker, ivabradine, fludrocortisone, and/or midodrine. #Includes maximal-effort
  exercise testing and/or an ambulatory rhythm monitor (see ). CMR = cardiac magnetic
  resonance imaging; COVID-19 = novel coronavirus disease 2019; CT = computed tomography;
  cTn = cardiac troponin; ECG = electrocardiogram, MCS = mechanical circulatory support;
  PASC = post-acute sequelae of SARS-CoV-2 infection; PASC-CVD = PASC-Cardiovascular
  Disease; PASC-CVS = PASC-Cardiovascular Syndrome; RTP = return to play; SARS-CoV-2
  = severe acute respiratory syndrome coronavirus 2.'
papertitle: '2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae
  of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute
  Sequelae of SARS-CoV-2 Infection, and Return to Play.'
reftext: ', et al. J Am Coll Cardiol. 2022 May 3;79(17):1717-1756.'
year: '2022'
doi: 10.1016/j.jacc.2022.02.003
journal_title: Journal of the American College of Cardiology
journal_nlm_ta: J Am Coll Cardiol
publisher_name: by the American College of Cardiology Foundation
keywords: ACC Expert Consensus Decision Pathway | athletes | cardiovascular diseases
  | chest pain | COVID-19 | myocarditis | SARS-CoV-2 | sports medicine | vaccines
automl_pathway: 0.6082048
figid_alias: PMC8926109__F2
figtype: Figure
redirect_from: /figures/PMC8926109__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8926109__gr2_lrg.html
  '@type': Dataset
  description: 'Framework for Evaluating and Managing Cardiovascular Sequelae of COVID-19
    in AdultsGold and purple boxes = COVID-19 symptoms. Orange boxes = cardiac testing.
    Red and blue boxes = diagnoses (sequelae). ∗Includes elevated cTn; ECG with diffuse
    T-wave inversion, ST-segment elevation without reciprocal ST-segment depression,
    and/or prolongation of the QRS complex duration; and echocardiogram with ventricular
    wall motion abnormalities, often in a noncoronary distribution, and/or abnormal
    ventricular strain. †Informed by the presentation and may include coronary angiography
    for suspected acute coronary syndrome or CT pulmonary angiography for suspected
    pulmonary embolism (see ). ‡Includes other laboratory testing (eg, complete blood
    count, basic metabolic panel, C-reactive protein), an ambulatory rhythm monitor,
    a chest X-ray or CT imaging, and pulmonary function tests, along with additional
    testing for suspected PASC-CVD or PASC-CVS (see ). §For patients with myocarditis,
    medical therapy may include immunosuppressive drugs (eg, corticosteroids); for
    patients with pericardial involvement, medical therapy may include nonsteroidal
    anti-inflammatory drugs, colchicine, and corticosteroids (see ). ‖See . ¶For patients
    with PASC-CVS, empiric medical therapy may include a beta-blocker, a non-dihydropyridine
    calcium-channel blocker, ivabradine, fludrocortisone, and/or midodrine. #Includes
    maximal-effort exercise testing and/or an ambulatory rhythm monitor (see ). CMR
    = cardiac magnetic resonance imaging; COVID-19 = novel coronavirus disease 2019;
    CT = computed tomography; cTn = cardiac troponin; ECG = electrocardiogram, MCS
    = mechanical circulatory support; PASC = post-acute sequelae of SARS-CoV-2 infection;
    PASC-CVD = PASC-Cardiovascular Disease; PASC-CVS = PASC-Cardiovascular Syndrome;
    RTP = return to play; SARS-CoV-2 = severe acute respiratory syndrome coronavirus
    2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - as
  - an
  - pain
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - wapl
  - if
  - 'On'
  - rtp
  - AN
  - SMCP
  - MOCOS
  - ZC4H2
  - NDRG1
  - MORN4
---
